肝炎围攻：免疫增强对抗病毒性肝炎。
A siege of hepatitis: immune boost for viral hepatitis.
机构信息
Center for Vaccines and Immunity, Nationwide Children's Hospital and Department of Pediatrics, The Ohio State University, Columbus, Ohio, USA.
出版信息
Nat Med. 2011 Mar;17(3):252-3. doi: 10.1038/nm0311-252.
Abstract
Finding mechanisms of viral resistance and new ways to tackle chronic hepatitis will help find a cure for this disease. In ‘Bench to Bedside’, Christopher Walker and Benoît Callendret highlight studies showing that overcoming immune exhaustion during chronic infection by blocking several inhibitory pathways of T cells may restore an adequate immune response. In ‘Bedside to Bench’, Lawrence Corey, Joshua Schiffer and John Scott discuss recent advances in antiviral therapy with protease inhibitors and the findings of a mathematical model that predicts possible single and double mutations prior to antiviral therapy.
摘要
寻找病毒耐药机制和解决慢性肝炎的新方法将有助于找到这种疾病的治愈方法。在“从实验室到临床”部分，Christopher Walker 和 Benoît Callendret 强调了一些研究，这些研究表明，通过阻断 T 细胞的几个抑制途径来克服慢性感染期间的免疫衰竭，可能会恢复适当的免疫反应。在“从临床到实验室”部分，Lawrence Corey、Joshua Schiffer 和 John Scott 讨论了蛋白酶抑制剂抗病毒治疗的最新进展，以及一个数学模型的发现，该模型预测了抗病毒治疗前可能出现的单突变和双突变。
相似文献
1
A siege of hepatitis: immune boost for viral hepatitis.肝炎围攻：免疫增强对抗病毒性肝炎。
Nat Med. 2011 Mar;17(3):252-3. doi: 10.1038/nm0311-252.
2
A siege of hepatitis: fighting a defiant virus.一场肝炎攻坚战：对抗顽强的病毒
Nat Med. 2011 Mar;17(3):253-4. doi: 10.1038/nm0311-253.
3
[Clinical efficacy of treating infant cytomegalovirus hepatitis with ganciclovir and impact on cytokines].更昔洛韦治疗婴儿巨细胞病毒肝炎的临床疗效及对细胞因子的影响
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2010 Nov;26(11):1130-2.
4
[New antiviral agents in chronic viral hepatitis].[慢性病毒性肝炎的新型抗病毒药物]
Rev Clin Esp. 1998 Feb;198(2):104-13.
5
Hepatitis. Advances in antiviral therapy for hepatitis.肝炎。肝炎抗病毒治疗的进展。
Lancet. 1998;352 Suppl 4:SIV15. doi: 10.1016/s0140-6736(98)90277-x.
6
VI International Symposium on Viral Hepatitis: summary.第六届国际病毒性肝炎研讨会：总结
J Hepatol. 1995;22(1 Suppl):160-4.
7
[Herpes simplex virus hepatitis; rare in immunocompetent patients].单纯疱疹病毒性肝炎；在免疫功能正常的患者中罕见
Ned Tijdschr Geneeskd. 2009;153:A55.
8
[Antiviral treatment of chronic hepatitis].[慢性肝炎的抗病毒治疗]
Internist (Berl). 1984 Dec;25(12):728-34.
9
New antiviral agents for viral hepatitis: our cup runneth over but is only half full.用于治疗病毒性肝炎的新型抗病毒药物：我们收获满满，但仍只达到了一半的目标。
Gastroenterology. 1999 Sep;117(3):525. doi: 10.1016/s0016-5085(99)70442-7.
10
International Journal of Antimicrobial Agents Themed Section Issue: "Therapeutics of hepatitis viruses".《国际抗菌剂杂志》专题栏目：“肝炎病毒的治疗学”。
Int J Antimicrob Agents. 2020 Jul;56(1):105402. doi: 10.1016/j.ijantimicag.2018.03.011. Epub 2018 Mar 21.
引用本文的文献
1
Both HCV Infection and Elevated Liver Stiffness Significantly Impacts on Several Parameters of T-Cells Homeostasis in HIV-Infected Patients.丙型肝炎病毒感染和肝脏硬度升高均对HIV感染患者T细胞稳态的多个参数产生显著影响。
J Clin Med. 2020 Sep 15;9(9):2978. doi: 10.3390/jcm9092978.
2
HCV coinfection contributes to HIV pathogenesis by increasing immune exhaustion in CD8 T-cells.丙型肝炎病毒合并感染通过增加CD8 T细胞中的免疫耗竭来促进HIV发病机制。
PLoS One. 2017 Mar 21;12(3):e0173943. doi: 10.1371/journal.pone.0173943. eCollection 2017.
3
Innate and Adaptive Immune Responses in Chronic HCV Infection.慢性丙型肝炎病毒感染中的固有免疫和适应性免疫反应
Curr Drug Targets. 2017;18(7):826-843. doi: 10.2174/1389450116666150825110532.
4
The Humoral Immune Response to HCV: Understanding is Key to Vaccine Development.HCV 的体液免疫反应：理解是疫苗开发的关键。
Front Immunol. 2014 Nov 10;5:550. doi: 10.3389/fimmu.2014.00550. eCollection 2014.
5
Immune control and failure in HCV infection--tipping the balance.丙型肝炎病毒感染中的免疫控制与失败——扭转平衡
J Leukoc Biol. 2014 Oct;96(4):535-48. doi: 10.1189/jlb.4RI0214-126R. Epub 2014 Jul 11.
6
Protective immunity against hepatitis C: many shades of gray.针对丙型肝炎的保护性免疫：诸多灰色地带。
Front Immunol. 2014 Jun 16;5:274. doi: 10.3389/fimmu.2014.00274. eCollection 2014.
7
Liver-primed CD8+ T cells suppress antiviral adaptive immunity through galectin-9-independent T-cell immunoglobulin and mucin 3 engagement of high-mobility group box 1 in mice.肝前体 CD8+T 细胞通过半乳糖凝集素-9 非依赖性 T 细胞免疫球蛋白和黏蛋白 3 与高迁移率族蛋白 B1 的结合来抑制抗病毒适应性免疫反应。
Hepatology. 2014 Apr;59(4):1351-65. doi: 10.1002/hep.26938. Epub 2014 Feb 28.
8
The role of chemokines in acute and chronic hepatitis C infection.趋化因子在丙型肝炎急性和慢性感染中的作用。
Cell Mol Immunol. 2014 Jan;11(1):25-40. doi: 10.1038/cmi.2013.37. Epub 2013 Aug 19.
9
Galectin-9 and IL-21 mediate cross-regulation between Th17 and Treg cells during acute hepatitis C.半乳糖凝集素-9 和白细胞介素-21 在丙型肝炎急性期调节 Th17 和 Treg 细胞之间的交叉调节。
PLoS Pathog. 2013;9(6):e1003422. doi: 10.1371/journal.ppat.1003422. Epub 2013 Jun 20.
10
Lipidoid Nanoparticles Containing PD-L1 siRNA Delivered In Vivo Enter Kupffer Cells and Enhance NK and CD8(+) T Cell-mediated Hepatic Antiviral Immunity.脂质纳米颗粒包载 PD-L1 siRNA 体内递送入枯否细胞并增强 NK 和 CD8(+) T 细胞介导的肝脏抗病毒免疫。
Mol Ther Nucleic Acids. 2013 Feb 19;2(2):e72. doi: 10.1038/mtna.2012.63.
本文引用的文献
1
Ribavirin for chronic hepatitis C: and the mystery goes on.利巴韦林治疗慢性丙型肝炎：谜团仍在。
Dig Liver Dis. 2011 Jun;43(6):425-30. doi: 10.1016/j.dld.2010.10.007. Epub 2010 Nov 18.
2
Tim-3 expression on PD-1+ HCV-specific human CTLs is associated with viral persistence, and its blockade restores hepatocyte-directed in vitro cytotoxicity.TIM-3 在 PD-1+HCV 特异性人 CTL 上的表达与病毒持续存在相关，其阻断可恢复肝细胞定向的体外细胞毒性。
J Clin Invest. 2010 Dec;120(12):4546-57. doi: 10.1172/JCI43127. Epub 2010 Nov 15.
3
The emerging toxicity profiles of anti-CTLA-4 antibodies across clinical indications.抗 CTLA-4 抗体在各种临床适应证中的新兴毒性特征。
Semin Oncol. 2010 Oct;37(5):499-507. doi: 10.1053/j.seminoncol.2010.09.007.
4
The immunoregulatory role of CD244 in chronic hepatitis B infection and its inhibitory potential on virus-specific CD8+ T-cell function.CD244 在慢性乙型肝炎感染中的免疫调节作用及其对病毒特异性 CD8+ T 细胞功能的抑制潜力。
Hepatology. 2010 Dec;52(6):1934-47. doi: 10.1002/hep.23936. Epub 2010 Nov 9.
5
Adaptive immunity to the hepatitis C virus.对丙型肝炎病毒的适应性免疫。
Adv Virus Res. 2010;78:43-86. doi: 10.1016/B978-0-12-385032-4.00002-1.
6
Coexpression of PD-1, 2B4, CD160 and KLRG1 on exhausted HCV-specific CD8+ T cells is linked to antigen recognition and T cell differentiation.PD-1、2B4、CD160 和 KLRG1 在耗竭的 HCV 特异性 CD8+ T 细胞上的共表达与抗原识别和 T 细胞分化有关。
PLoS Pathog. 2010 Jun 10;6(6):e1000947. doi: 10.1371/journal.ppat.1000947.
7
Rapid emergence of protease inhibitor resistance in hepatitis C virus.丙型肝炎病毒蛋白酶抑制剂耐药性的快速出现。
Sci Transl Med. 2010 May 5;2(30):30ra32. doi: 10.1126/scitranslmed.3000544.
8
Integrating genomic signatures for immunologic discovery.整合基因组特征以进行免疫发现。
Immunity. 2010 Feb 26;32(2):152-61. doi: 10.1016/j.immuni.2010.02.001.
9
Antiviral resistance and specifically targeted therapy for HCV (STAT-C).丙型肝炎病毒的抗病毒耐药性及特异性靶向治疗（STAT-C）
J Viral Hepat. 2009 Jun;16(6):377-87. doi: 10.1111/j.1365-2893.2009.01124.x.
10
Synergistic reversal of intrahepatic HCV-specific CD8 T cell exhaustion by combined PD-1/CTLA-4 blockade.通过联合阻断PD-1/CTLA-4协同逆转肝内丙型肝炎病毒特异性CD8 T细胞耗竭
PLoS Pathog. 2009 Feb;5(2):e1000313. doi: 10.1371/journal.ppat.1000313. Epub 2009 Feb 27.
Zotero 插件